Clinical Trial Update: Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults

View source ↗

Summary

A completed clinical trial comparing virologic and immunologic responses to raltegravir and dolutegravir in the gastrointestinal tract of HIV-positive adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Dolutegravir (dolutegravir)
• Raltegravir (raltegravir)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Human Immunodeficiency Virus | Status: COMPLETED | Results posted: 2018-10-29